-
Full Article (HTML) (140) -
Full Article (PDF) (71) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9060)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 14, 2019 (publication date) through Oct 18, 2021
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bruno G, Zaccari P, Rocco G, Scalese G, Panetta C, Porowska B, Pontone S, Severi C. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol 2019; 25(22): 2706-2719 [PMID: 31235994 DOI: 10.3748/wjg.v25.i22.2706] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i22/2706.htm |
| Number | Citing Articles |
| 1 |
Asimina Koulouridi, Ippokratis Messaritakis, Nikolaos Gouvas, John Tsiaoussis, John Souglakos. Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal Cancer. Cancers 2020; 13(1): 43 doi: 10.3390/cancers13010043
|
| 2 |
Leon Fisher, Alexander Fisher, Paul N Smith. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). Journal of Clinical Medicine 2020; 9(10): 3253 doi: 10.3390/jcm9103253
|
| 3 |
Louis Gaucher, Leslie Adda, Alice Séjourné, Camille Joachim, Chaby Guillaume, Claire Poulet, Sophie Liabeuf, Valérie Gras-Champel, Kamel Masmoudi, Aline Houessinon, Youssef Bennis, Benjamin Batteux. Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors. Therapeutic Advances in Medical Oncology 2021; 13: 175883592110005 doi: 10.1177/17588359211000591
|
| 4 |
Muhammad Miftahussurur, Boby Pratama Putra, Yoshio Yamaoka. The Potential Benefits of Vonoprazan as Helicobacter pylori Infection Therapy. Pharmaceuticals 2020; 13(10): 276 doi: 10.3390/ph13100276
|
| 5 |
Irene Gullo, Catarina Costa, Susana L. Silva, Cristina Ferreira, Adriana Motta, Sara P. Silva, Rúben Duarte Ferreira, Pedro Rosmaninho, Emília Faria, José Torres da Costa, Rita Câmara, Gilza Gonçalves, João Santos-Antunes, Carla Oliveira, José C. Machado, Fátima Carneiro, Ana E. Sousa. The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric Cancer. Cells 2020; 9(6): 1498 doi: 10.3390/cells9061498
|
| 6 |
Zhi‐Hang Tao, Ji‐Xuan Han, Jing‐Yuan Fang.
Helicobacter pylori
infection and eradication: Exploring their impacts on the gastrointestinal microbiota
. Helicobacter 2020; 25(6) doi: 10.1111/hel.12754
|
| 7 |
Judith Wellens, João Sabino, Séverine Vermeire. PPIs and anti-TNF in patients with IBD: a forbidden combination?. Gut 2021; : gutjnl-2021-324040 doi: 10.1136/gutjnl-2021-324040
|
| 8 |
Ana Almeida-Santos, Daniela Martins-Mendes, Magdalena Gayà-Vidal, Lucía Pérez-Pardal, Albano Beja-Pereira. Characterization of the Oral Microbiome of Medicated Type-2 Diabetes Patients. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.610370
|
| 9 |
Claudio Barbiellini Amidei, Rosanna Comoretto, Loris Zanier, Daniele Donà, Anna Cantarutti, Cristina Canova. Acid-suppressive medications in the first year of life and risk of childhood asthma: a population-based birth cohort study. European Respiratory Journal 2020; 56(5): 2000197 doi: 10.1183/13993003.00197-2020
|
| 10 |
Jong Min Park, Won Hee Lee, Hochan Seo, Ji Young Oh, Dong Yoon Lee, Seong Jin Kim, Ki Baik Hahm. Microbiota changes with fermented kimchi contributed to either the amelioration or rejuvenation of <i>Helicobacter pylori</i>-associated chronic atrophic gastritis. Journal of Clinical Biochemistry and Nutrition 2021; 69(1): 98 doi: 10.3164/jcbn.20-123
|
| 11 |
Joshua Bilello, Ikenna Okereke. Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome. Biomedicines 2021; 9(6): 617 doi: 10.3390/biomedicines9060617
|
| 12 |
Nele Brusselaers, Jesper Lagergren, Lars Engstrand. Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer. Cancer Epidemiology 2019; 62: 101585 doi: 10.1016/j.canep.2019.101585
|
| 13 |
Volker Schirrmacher. Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism. Biomedicines 2020; 8(11): 526 doi: 10.3390/biomedicines8110526
|
| 14 |
I. A. Krylova, V. I. Kupaev, A. V. Ljamin. Microbiological Characteristics of Intestinal Biocenosis of Ambulator Patients Having Behavioral Risk Factors for Chronic Non-Communicable Diseases. The Russian Archives of Internal Medicine 2021; 11(3): 217 doi: 10.20514/2226-6704-2021-11-3-217-224
|
| 15 |
Thomas X Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba. The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies. Gut 2021; 70(11): 2076 doi: 10.1136/gutjnl-2020-321609
|
| 16 |
Nadji Hannachi, Laurence Camoin-Jau. Drug Response Diversity: A Hidden Bacterium?. Journal of Personalized Medicine 2021; 11(5): 345 doi: 10.3390/jpm11050345
|
| 17 |
Enrico Pierluigi Spugnini, Stefano Fais. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors. Expert Opinion on Therapeutic Patents 2020; 30(1): 15 doi: 10.1080/13543776.2020.1704733
|
| 18 |
M. Yadav, N.S. Chauhan. Overview of the rules of the microbial engagement in the gut microbiome: a step towards microbiome therapeutics. Journal of Applied Microbiology 2021; 130(5): 1425 doi: 10.1111/jam.14883
|
| 19 |
Luis A. García Rodríguez, Angel Lanas, Montse Soriano-Gabarró, Pareen Vora, Lucía Cea Soriano. Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study. Journal of Clinical Medicine 2020; 9(4): 928 doi: 10.3390/jcm9040928
|
| 20 |
Issac E. Perry, Irene Sonu, Carmelo Scarpignato, Junichi Akiyama, Michio Hongo, Kenneth J. Vega. Potential proton pump inhibitor–related adverse effects. Annals of the New York Academy of Sciences 2020; 1481(1): 43 doi: 10.1111/nyas.14428
|
| 21 |
Aleksandra Danielak, John L Wallace, Tomasz Brzozowski, Marcin Magierowski. Gaseous Mediators as a Key Molecular Targets for the Development of Gastrointestinal-Safe Anti-Inflammatory Pharmacology. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.657457
|
| 22 |
Hüseyin S Bozkurt, Ömer Bilen. Gastrointestinal symptoms in COVID-19 could be associated with severe lung involvement and increased readmission rates. European Journal of Inflammation 2021; 19: 205873922110482 doi: 10.1177/20587392211048259
|
| 23 |
Claudio Barbiellini Amidei, Fabiana Zingone, Loris Zanier, Cristina Canova. Risk of Prevalent Asthma among Children Affected by Inflammatory Bowel Disease: A Population-Based Birth Cohort Study. International Journal of Environmental Research and Public Health 2020; 17(12): 4255 doi: 10.3390/ijerph17124255
|
| 24 |
Anna Cantarutti, Claudio Barbiellini Amidei, Camilla Valsecchi, Antonio Scamarcia, Giovanni Corrao, Dario Gregori, Carlo Giaquinto, Jonas Ludvigsson, Cristina Canova. Association of Treated and Untreated Gastroesophageal Reflux Disease in the First Year of Life with the Subsequent Development of Asthma. International Journal of Environmental Research and Public Health 2021; 18(18): 9633 doi: 10.3390/ijerph18189633
|
| 25 |
Pamela A. McCombe, Fleur C Garton, Matthew Katz, Naomi R Wray, Robert D Henderson. What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?. Expert Review of Neurotherapeutics 2020; 20(9): 921 doi: 10.1080/14737175.2020.1785873
|
| 26 |
Manyu Li, Chaofan Zeng, Jiannan Yao, Yang Ge, Guangyu An. The association between proton pump inhibitors use and clinical outcome of patients receiving immune checkpoint inhibitors therapy. International Immunopharmacology 2020; 88: 106972 doi: 10.1016/j.intimp.2020.106972
|
| 27 |
Youssef Bouferraa, Andrea Chedid, Ghid Amhaz, Ahmed El Lakkiss, Deborah Mukherji, Sally Temraz, Ali Shamseddine. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges. International Journal of Molecular Sciences 2021; 22(15): 8036 doi: 10.3390/ijms22158036
|
| 28 |
Nadiya Hussain, Muntaha Naeem, David J. Pinato. Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?. Human Vaccines & Immunotherapeutics 2021; 17(1): 55 doi: 10.1080/21645515.2020.1769398
|
| 29 |
Axel Dalhoff. Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?. Infection 2021; 49(4): 569 doi: 10.1007/s15010-020-01547-9
|
| 30 |
Sadia Tasnim, Aaron L. Miller, Daniel C. Jupiter, Catherine F. Hamilton, Gabriel L. Reep, Timothy S. Krill, Richard B. Pyles, Ikenna C. Okereke. Effects of proton pump inhibitor use on the esophageal microbial community. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01460-3
|
| 31 |
Rodney R. Dietert. Microbiome First Medicine in Health and Safety. Biomedicines 2021; 9(9): 1099 doi: 10.3390/biomedicines9091099
|
| 32 |
Alessio Cortellini, Marco Tucci, Vincenzo Adamo, Luigia Stefania Stucci, Alessandro Russo, Enrica Teresa Tanda, Francesco Spagnolo, Francesca Rastelli, Renato Bisonni, Daniele Santini, Marco Russano, Cecilia Anesi, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Mario Alberto Occhipinti, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Claudia Bareggi, Olga Nigro, Alessandro Tuzi, Michele De Tursi, Nicola Petragnani, Laura Pala, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Barbara Di Cocco, Domenico Mallardo, Maria Grazia Vitale, David James Pinato, Giampiero Porzio, Corrado Ficorella, Paolo Antonio Ascierto. Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice. Journal for ImmunoTherapy of Cancer 2020; 8(2): e001361 doi: 10.1136/jitc-2020-001361
|
| 33 |
Larissa Spósito, Giovanna Capaldi Fortunato, Bruna Almeida Furquim de Camargo, Matheus Aparecido dos Santos Ramos, Maurício Palmeira Chaves de Souza, Andréia Bagliotti Meneguin, Taís Maria Bauab, Marlus Chorilli. Exploiting drug delivery systems for oral route in the peptic ulcer disease treatment. Journal of Drug Targeting 2021; : 1 doi: 10.1080/1061186X.2021.1904249
|
| 34 |
Kiera Murphy, R. Paul Ross, C. Anthony Ryan, Eugene M. Dempsey, Catherine Stanton. Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing Enterocolitis. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.667188
|
| 35 |
Sofia D. Forssten, Arthur C. Ouwehand. Reference Module in Food Science. 2021; doi: 10.1016/B978-0-12-819265-8.00059-0
|
| 36 |
Manon Cairat, Marie Al Rahmoun, Marc J. Gunter, Gianluca Severi, Laure Dossus, Agnès Fournier. Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women. Breast Cancer Research 2020; 22(1) doi: 10.1186/s13058-020-01343-1
|
| 37 |
Cunye Yan, Yue Chen, Chenyu Sun, Mubashir Ayaz Ahmed, Chandur Bhan, Zhichun Guo, Hongru Yang, Yijing Zuo, Yue Yan, Lei Hu, Yiceng Sun, Yao Li, Qin Zhou. Will Proton Pump Inhibitors Lead to a Higher Risk of COVID-19 Infection and Progression to Severe Disease? A Meta-analysis. Japanese Journal of Infectious Diseases 2021; doi: 10.7883/yoken.JJID.2021.074
|
| 38 |
Andreas Thalheimer. Chirurgische Behandlung der Refluxkrankheit. Im OP 2021; 11(03): 105 doi: 10.1055/a-1220-4293
|
| 39 |
Andrea Nuzzo, James R. Brown. The Microbiome Factor in Drug Discovery and Development. Chemical Research in Toxicology 2020; 33(1): 119 doi: 10.1021/acs.chemrestox.9b00333
|
| 40 |
Piotr Dziechciarz, Katarzyna Krenke, Hania Szajewska, Andrea Horvath.
Lactobacillus rhamnosus GG Usage in the Prevention of Gastrointestinal and Respiratory Tract Infections in Children with Gastroesophageal Reflux Disease Treated with Proton Pump Inhibitors: A Randomized Double-Blinded Placebo-Controlled Trial. Pediatric Gastroenterology, Hepatology & Nutrition 2020; 23(3): 251 doi: 10.5223/pghn.2020.23.3.251
|
| 41 |
Yasutoshi Shiratori, Takashi Ikeya, Naoki Ishii, Kazuki Yamamoto, Tetsuro Honda, Kenkei Hasatani, Naohiro Yoshida, Tsutomu Nishida, Tetsuya Sumiyoshi, Shu Kiyotoki, Masahiro Arai, Ryota Niikura. Association between the chronic use of gastric acid suppressants and high‐risk colorectal polyps. JGH Open 2021; 5(3): 371 doi: 10.1002/jgh3.12503
|
| 42 |
Mauro Giuffrè, Michele Campigotto, Giuseppina Campisciano, Manola Comar, Lory Saveria Crocè. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(5): G889 doi: 10.1152/ajpgi.00161.2019
|
| 43 |
Fang Lu, Yurong Ma, Hui Huang, Yue Zhang, Hui Kong, Yan Zhao, Huihua Qu, Qingguo Wang, Yang Liu, Zhenhui Kang. Edible and highly biocompatible nanodots from natural plants for the treatment of stress gastric ulcers. Nanoscale 2021; 13(14): 6809 doi: 10.1039/D1NR01099A
|
| 44 |
Marzena Jabczyk, Justyna Nowak, Bartosz Hudzik, Barbara Zubelewicz-Szkodzińska. Microbiota and Its Impact on the Immune System in COVID-19—A Narrative Review. Journal of Clinical Medicine 2021; 10(19): 4537 doi: 10.3390/jcm10194537
|
| 45 |
Nele Brusselaers, Omid Sadr-Azodi, Lars Engstrand. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden. Journal of Gastroenterology 2020; 55(4): 453 doi: 10.1007/s00535-019-01652-z
|
| 46 |
Thiruvinvamalai S. Dharmarajan. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing. Journal of the American Medical Directors Association 2021; 22(1): 15 doi: 10.1016/j.jamda.2020.09.046
|
| 47 |
Alexander J Friedman, Anna J Elseth, Joel R Brockmeyer. Proton Pump Inhibitors, Associated Complications, and Alternative Therapies: A Shifting Risk Benefit Ratio. The American Surgeon 2021; : 000313482199198 doi: 10.1177/0003134821991988
|
| 48 |
Shingo Takashima, Fumio Tanaka, Yunosuke Kawaguchi, Yuki Usui, Kosuke Fujimoto, Yuji Nadatani, Koji Otani, Shuhei Hosomi, Yasuaki Nagami, Noriko Kamata, Koichi Taira, Tetsuya Tanigawa, Toshio Watanabe, Seiya Imoto, Satoshi Uematsu, Yasuhiro Fujiwara. Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice. Neurogastroenterology & Motility 2020; 32(7) doi: 10.1111/nmo.13841
|
| 49 |
Li-Qi Mao, Yan-Lin Zhou, Shuang-Shuang Wang, Lin Chen, Yue Hu, Lei-Min Yu, Jing-Ming Xu, Bin Lyu. Impact of Helicobacter pylori eradication on the gastric microbiome. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00460-2
|
| 50 |
Heidi Cecilie Villmones, Adrian Halland, Tore Stenstad, Elling Ulvestad, Harald Weedon-Fekjær, Øyvind Kommedal. The cultivable microbiota of the human distal ileum. Clinical Microbiology and Infection 2021; 27(6): 912.e7 doi: 10.1016/j.cmi.2020.08.021
|
| 51 |
Aws Hasan, Laith K. Hasan, Bernd Schnabl, Madeline Greytak, Rena Yadlapati. Microbiome of the Aerodigestive Tract in Health and Esophageal Disease. Digestive Diseases and Sciences 2021; 66(1): 12 doi: 10.1007/s10620-020-06720-6
|